Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Dose-Escalation Study of GSK2126458 (FTIH)

This study has been completed.
Information provided by (Responsible Party):
GlaxoSmithKline Identifier:
First received: September 3, 2009
Last updated: August 12, 2016
Last verified: August 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2015
  Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)